CLINICAL_TRIALS
trial_result
· 2020-08-25
Clinical Trial Update: Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer [Phase 2]
Summary
Phase 2 trial evaluating pasireotide plus everolimus in adult patients with radioiodine-refractory differentiated and medullary thyroid cancer has completed wit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-08-25